Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare CRISABOROLE (Eucrisa) and Lebrikizumab (Ebglyss) — clinical data, side effects, and patient experiences.
Eucrisa · Other
How it works
12.1 Mechanism of Action Crisaborole is a phosphodiesterase 4 (PDE-4) inhibitor. PDE-4 inhibition results in increased intracellular cyclic adenosine monophosphate (cAMP) levels. T...
Approved for
Ebglyss · Biologic (IL-13 Inhibitor)
How it works
High-affinity monoclonal antibody that selectively binds IL-13 and prevents formation of the IL-13Rα1/IL-4Rα heterodimer signalling complex.
Approved for
Estimated frequency (%) based on clinical trial data
Based on 7 Reddit discussions
CRISABOROLE
0%
positive
0 threads
Lebrikizumab
29%
positive
7 threads
% of discussions mentioning each side effect
No community discussions found for CRISABOROLE yet.
7 Reddit threads analysed for Lebrikizumab
Overall Sentiment
Mixed
Comparison Threads
1
Avg Post Score
6 upvotes
Most discussed side effects in community
Threads directly comparing Lebrikizumab to other medications
I’ve been on Adbry for almost 11 months now and I’ve seen quite good improvement during the Sommer months but now it’s winter and it doesn’t seem to be really effective. I read all the studies and it’s generally mentioned that Lebrikizumab has a better efficacy and I wonder if anyone has tried both
This content is intended for US-based consumers and HCPs. Dr. April Armstrong is Professor and Chief of Dermatology at UCLA, and an internationally recognized expert in inflammatory skin diseases. She has led over 150 clinical trials and published more than 500 scientific articles. Her federally fun
Hi, hope you're all well. I'd just like to give you my experience with dupilumab so far and get your thoughts if that's ok? I'm both lucky and unlucky with my eczema. Unlucky in the sense that I have 100% coverage. Without treatment, every square inch of my skin is very dry, becomes inflamed a
HELLO FROM THE UK 21 YEARS OLD i’ve been suffering with eczema and recently i’ve had to be hospitalised with staph infection , its been cleared from my bloodstream but the staph seems to not stop growing on my face and infecting my face, my eczema is controlled and well but the staph seems to be mak
HELLO FROM THE UK 21 YEARS OLD i’ve been suffering with eczema and recently i’ve had to be hospitalised with staph infection , its been cleared from my bloodstream but the staph seems to not stop growing on my face and infecting my face, my eczema is controlled and well but the staph seems to be mak
Hi there! For context, I've (23F) been struggling with severe atopic dermatitis pretty much my whole life with some pauses due to medications I've taken or random changes my body has had. During the last 2 years i was on a trial for lebrikizumab which was going pretty okay, and for the last ≈10 mont
I’m being taken off of Dupixent due to severe facial flares and eye issues, I’m now going onto Lebrikizumab. Any experiences with this switch?
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
CRISABOROLE is a Other, while Lebrikizumab belongs to the Biologic (IL-13 Inhibitor) class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. CRISABOROLE is administered via Topical, whereas Lebrikizumab uses Subcutaneous. Route of administration can affect onset of action and patient adherence.
CRISABOROLE carries 1 FDA warning. Lebrikizumab carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.